Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Remi A. Nout"'
Autor:
Patrick L. Y. Tang, Alejandra Méndez Romero, Remi A. Nout, Caroline van Rij, Cleo Slagter, Annemarie T. Swaak-Kragten, Marion Smits, Esther A. H. Warnert
Publikováno v:
European Radiology Experimental, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Background Extensive glioblastoma infiltration justifies a 15-mm margin around the gross tumor volume (GTV) to define the radiotherapy clinical target volume (CTV). Amide proton transfer (APT)-weighted imaging could enable visualization of t
Externí odkaz:
https://doaj.org/article/8ca38a2fcb0a4bdf95de0b48e77a133d
Autor:
Lucy A. van Werkhoven, Eugenio Cammareri, Mischa S. Hoogeman, Remi A. Nout, Maaike T.W. Milder, Joost J.M.E. Nuyttens
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: To review available data on toxicity during and/or after treatment of abdominal-pelvic lymph node oligometastases (A-P LN) with stereotactic body radiation therapy (SBRT) and to provide an overview of adverse events and its re
Externí odkaz:
https://doaj.org/article/24a842680ed6453889dbb26702f5be7f
Autor:
Joris B. W. Elbers, Pascal A. Gunsch, Reno Debets, Stijn Keereweer, Esther van Meerten, Jaap Zindler, Yvette van Norden, Mischa S. Hoogeman, Gerda M. Verduijn, Michiel Kroesen, Remi A. Nout
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Radiotherapy (RT) is the standard of care for most advanced head and neck squamous cell carcinoma (HNSCC) and results in an unfavorable 5-year overall survival of 40%. Despite strong biological rationale, combining RT with immune
Externí odkaz:
https://doaj.org/article/99efa176368845d2afb49461b163fd8d
Autor:
Nanda Horeweg, Hagma H. Workel, Dominik Loiero, David N. Church, Lisa Vermij, Alicia Léon-Castillo, Ricki T. Krog, Stephanie M. de Boer, Remi A. Nout, Melanie E. Powell, Linda R. Mileshkin, Helen MacKay, Alexandra Leary, Naveena Singh, Ina M. Jürgenliemk-Schulz, Vincent T. H. B. M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn, TransPORTEC consortium
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Tertiary lymphoid structures (TLS) are associated with a reduced risk of cancer recurrence and improved response to immune checkpoint blockade in several tumor types. Here the authors identify L1CAM as a marker for mature TLS and show that the presen
Externí odkaz:
https://doaj.org/article/6cc5d5b840f843b2b959b31b5c279a0f
Publikováno v:
3D Printing in Medicine, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Brachytherapy involves placement of radioactive sources inside or near the tumour. For gynaecological cancer, recent developments, including 3D imaging and image-guided adaptive brachytherapy, have improved treatment quality and o
Externí odkaz:
https://doaj.org/article/ed6670c4ffa942618f5772ab7ceedee0
Autor:
Astrid A.C. De Leeuw, Remi A. Nout, Ruud G.H. Van Leeuwen, Anton Mans, Lia G. Verhoef, Ina Maria Jürgenliemk-Schulz
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 9, Iss , Pp 1-7 (2019)
Purpose: To report on the “Dutch Quality Improvement Project” regarding external beam (EBRT) and brachytherapy (BT) contouring and treatment planning for locally advanced cervical cancer (LACC). Material and methods: Two rounds of three workshops
Externí odkaz:
https://doaj.org/article/76adae9ceec9490cbe7f3a98043e9f97
Autor:
Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J Jobsen, Mariel Brinkhuis, Suzan Roothaan, Ina Jurgenliemk-Schulz, Ludy C H W Lutgens, Remi A Nout, Elzbieta M van der Steen-Banasik, Stephanie M de Boer, Melanie E Powell, Naveena Singh, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Vincent T H B M Smit, Carien L Creutzberg, Nanda Horeweg, Viktor H Koelzer, Tjalling Bosse
Publikováno v:
The Lancet Digital Health, 5(2), e71-e82. Lancet Publishing Group
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
Background: Endometrial cancer can be molecularly classified into POLEmut, mismatch repair deficient (MMRd), p53 abnormal (p53abn), and no specific molecular profile (NSMP) subgroups. We aimed to develop an interpretable deep learning pipeline for wh
Autor:
Rica Capistrano I., Sonz Paul, Ingrid Boere, Pan Pantziarka, Supriya Chopra, Remi A Nout, Gauthier Bouche
Publikováno v:
International Journal of Gynecological Cancer, 32(11):ijgc-2022-003585, 1377-1386. BMJ Publishing Group
ObjectiveDrug repurposing is an alternative development pathway that utilizes the properties of drugs approved for other diseases and builds on available safety and pharmacological data to develop the drug as a potential treatment for other diseases.
Autor:
David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Felix, Daniela Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Kohler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Mr Raj Naik, Remi A Nout, Ana Oaknin, Fedro Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian P. Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Lindegaard
Publikováno v:
Cibula, D, Rosaria Raspollini, M, Planchamp, F, Centeno, C, Chargari, C, Felix, A, Fischerová, D, Jahnn-Kuch, D, Joly, F, Kohler, C, Lax, S, Lorusso, D, Mahantshetty, U, Mathevet, P, Raj Naik, M, Nout, R A, Oaknin, A, Peccatori, F, Persson, J, Querleu, D, Rubio Bernabé, S, Schmid, M P, Stepanyan, A, Svintsitskyi, V, Tamussino, K, Zapardiel, I & Lindegaard, J 2023, ' ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023 ', Radiotherapy and Oncology, vol. 184, 109682 . https://doi.org/10.1016/j.radonc.2023.109682
Funding Information: The authors thank ESGO, ESTRO, and ESP for their support. The authors also thank the 155 international reviewers (physicians and patient representatives, see Appendix 2 in Online Supplemental File 2) for their valuable comments a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65f0323ffe81b41bb05a0de9ce3192b
https://pure.au.dk/portal/da/publications/esgoestroesp-guidelines-for-the-management-of-patients-with-cervical-cancer--update-2023(a7a7a4ad-5b3a-4fb0-8db3-a3c06ec7558b).html
https://pure.au.dk/portal/da/publications/esgoestroesp-guidelines-for-the-management-of-patients-with-cervical-cancer--update-2023(a7a7a4ad-5b3a-4fb0-8db3-a3c06ec7558b).html
Autor:
Jacob Christian Lindegaard, Primoz Petric, Maximilian Paul Schmid, Nicole Nesvacil, Christine Haie-Meder, Lars Ulrik Fokdal, Alina Emiliana Sturdza, Peter Hoskin, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Fleur Huang, Bhavana Rai, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik Van Limbergen, Bradley Rumwell Pieters, Li-Tee Tan, Remi A. Nout, Astrid Agatha Catharina De Leeuw, Kathrin Kirchheiner, Sofia Spampinato, Ina Jürgenliemk-Schulz, Kari Tanderup, Christian Kirisits, Richard Pötter
Publikováno v:
Lindegaard, J C, Petric, P, Schmid, M P, Nesvacil, N, Haie-Meder, C, Fokdal, L U, Sturdza, A E, Hoskin, P, Mahantshetty, U, Segedin, B, Bruheim, K, Huang, F, Rai, B, Cooper, R, van der Steen-Banasik, E, Van Limbergen, E, Pieters, B R, Tan, L T, Nout, R A, De Leeuw, A A C, Kirchheiner, K, Spampinato, S, Jürgenliemk-Schulz, I, Tanderup, K, Kirisits, C & Pötter, R 2022, ' Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study ', International Journal of Radiation Oncology Biology Physics, vol. 113, no. 2, pp. 379-389 . https://doi.org/10.1016/j.ijrobp.2022.02.005
International Journal of Radiation Oncology Biology Physics, 113(2), 379-389. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics, 113(2), 379-389. Elsevier Inc.
Purpose: A simple scoring system (T-score, TS) for integrating findings from clinical examination and magnetic resonance imaging (MRI) of the primary tumor at diagnosis has shown strong prognostic capability for predicting local control and survival